BioSpace News Archive

Business

Vectura Group plc: Interim Results For The Six Months Ended 30 June 2018

Vectura regaining momentum with continued inhaled revenue and adjusted EBITDA growth

September 12, 2018
·
6 min read
Driving real-time productivity insights with connected laboratory automation

Tecan is offering its customers unprecedented insight into how their Fluent® and Freedom EVO® liquid handing platforms are being used, thanks to its Introspect™ and Common Notification System (Tecan CNS™) software tools.

September 12, 2018
·
3 min read
Business

Cushman & Wakefield: Life Sciences Driving Improved Office Fundamentals in N.J.

Sector Generates Significant Year-to-Date Leasing Volume – with More to Come

September 12, 2018
·
3 min read
Novo Holdings invests CHF 6.8 Million in Polyphor to accelerate the development of novel antibiotics against multi-drug resistant Gram-negative pathogens

Novo REPAIR Impact Fund to invest up to CHF 11.5M in Polyphor’s antibiotic OMPTA pipeline through a CHF 6.8M equity investment, as well as a potential additional CHF 4.7M investment against program-specific royalties

September 12, 2018
·
4 min read
Clinithink receives RARE Champion of Hope award for their ‘notable efforts’ in rare disease

Clinithink has been selected to receive the RARE Champion of Hope – Collaborations in Science and Technology award at the 7th Annual RARE Patient Advocacy Summit on October 4th in Irvine, California.

September 12, 2018
·
2 min read
Business

CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement

CURE grants cannabis leader rights to its proprietary drug delivery technology in markets around the world

September 12, 2018
·
3 min read
Rostec presents modernized robotic nurse

Concern Tecmash (part of Rostec) has presented the first sample of modernized Angel automated diagnostic and therapeutic system for human life support at the BIOTECHMED forum.

September 12, 2018
·
4 min read
Drug Development

Imugene Completes Phase 1b Cancer Vaccine Trial Recruitment

Imugene Limited today announced the Phase 1b clinical trial of its HER-Vaxx cancer vaccine in HER-2 gastric cancer patients had completed recruitment.

September 12, 2018
·
4 min read
Business

Expedeon AG announces commercial-use licence of proprietary technology in diagnostic assay

Expedeon AG today announced the signing of a licence and supply agreement for its colloidal gold with South Korea-based PaxGenBio, a privately held, independent developer and supplier of rapid, highly sensitive multiplex diagnostic kits.

September 12, 2018
·
3 min read
Drug Development

Foamix Announces Positive Topline Results from Third Phase 3 Trial (Study FX2017-22) Evaluating FMX101 Topical Minocycline Foam for Moderate-to-Severe Acne

FMX101 Demonstrated Highly Statistically Significant Improvement Compared with Vehicle in Both Co-Primary Efficacy Endpoints

September 12, 2018
·
7 min read